August 8, 2007 – Analysis conducted by Millenium Research Group (MRG) indicates that the 2005 Deficit Reduction Act (DRA) is forcing many diagnostic imaging centers (DIC) to streamline operations in order to stay profitable and many are adopting PACS as a result.

Because PACS is a major investment, PACS vendors are being challenged to offer systems that smaller facilities can afford.

August 8, 2007 - Masimo Corp. announced the pricing of its initial public offering of 11,916,626 shares of common stock at a price of $17 per share.

Masimo intends to use the net proceeds from the offering for capital expenditures and the placement of equipment, sales and marketing activities to support the ongoing commercialization of the Masimo SET and Masimo Rainbow SET pulse oximetry products, sales force expansion, research and development activities and including support of hardware and software product development and clinical study initiatives.

August 8, 2007 - Orbotech Ltd. announced that it has signed a definitive agreement to acquire 3D - Danish Diagnostic Development A/S (DDD), a privately-held Danish company that develops and manufactures gamma cameras for nuclear medicine, as part of a strategy to generate a projected $30 million in annual revenues, which is expected to be immediately accretive to Orbotech on a non-GAAP basis.

August 8, 2007 – Accuray Inc. announced that use of its CyberKnife Robotic Radiosurgery System to noninvasively treat extracranial tumors has increased 75 percent in 2007.

The number of lung cancer patients treated with the system doubled, while the number of prostate cancer procedures with the system quadrupled over the past year.

Radiosurgery has historically been used exclusively for the treatment of brain tumors. The CyberKnife System, however, is FDA cleared to treat tumors anywhere in the body, including the spine, lungs, prostate, liver and pancreas.

August 8, 2007 – The National Cancer Institute (NCI)/National Institutes of Health (NIH) have awarded TechniScan Medical Systems, developer of ultrasound technology for breast imaging, Phase II grant monies for prototype construction of its UltraSound CT scanning system.

August 8, 2007 – Emageon Inc. reported financial results for its second quarter ended June 30, 2007, reflecting net positive operating cash flow of $3.7 million for the second quarter of 2007, an improvement of $7.7 million over net negative operating cash flow of $4.0 million in first quarter 2007. For the six months ended June 30, 2007, net cash used in operations was $0.3 million. At June 30, 2007, cash and marketable securities totaled $20.9 million, compared to $23.0 million at December 31, 2006.

August 7, 2007 - A national survey reveals that due to a lack of information about symptoms, risk and treatment options, many women suffering with uterine fibroids remain untreated for up to a year or longer.

The study was conducted by Caravan Research Corp. and sponsored by BioSphere Medical Inc.

August 7, 2007 - BSD Medical Corp. announced that the Centers for Medicare and Medicaid Services (CMS) has proposed an approximate 86 percent increase in the reimbursement rate for all of the CMS codes applicable to the use of BSD cancer treatment systems for hospital outpatient procedures.

The new proposed reimbursement rates will be finalized in November and become effective Jan. 1, 2008. Increases ranging from 14 to 44 percent have also been proposed for freestanding clinics.

August 7, 2007 - Spring Medical Systems announced it has formed a strategic alliance with WFS Services Inc. to provide an integrated and cost-effective technology solution that will allow small- to medium-sized medical practices to move to an electronic health records (EHR) solution and at the same time, to enhance financial and billing procedures.

August 7, 2007 — Cardinal Health introduced its Esteem Micro Powder-Free Synthetic Surgical Glove, a versatile solution for procedures that require a more refined touch or for use as an outerglove when double gloving.

A thinner version of the Esteem SMT glove, the Esteem Micro glove is made from a unique and proprietary polyisoprene formulation that is nearly identical to Natural Rubber Latex (NRL). It reportedly has the fit, feel and performance of NRL, without any of the protein allergens.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now